Prevalence of high risk HPV DNA in esophagus is high in Brazil but not related to esophageal squamous cell carcinoma

Carregando...
Imagem de Miniatura
Citações na Scopus
5
Tipo de produção
article
Data de publicação
2018
Título da Revista
ISSN da Revista
Título do Volume
Editora
F HERNANDEZ
Autores
COSTA, Allini Mafra da
FREGNANI, Jose Humberto Tavares Guerreiro
PASTREZ, Paula Roberta Aguiar
MARIANO, Vania Sammartino
SCAPULATEMPO NETO, Cristovam
GUIMARAES, Denise Peixoto
OLIVEIRA, Kelly Menezio Giordina de
ZEMI NETO, Said Abdala
Citação
HISTOLOGY AND HISTOPATHOLOGY, v.33, n.4, p.357-363, 2018
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background. The first publication that associated Human Papillomavirus (HPV) infection and esophageal cancer was published in 1982. However, data are still contradictory and require further investigation. The aim of this study was to identify high risk HPV DNA in esophageal tissue of patients with and without esophageal squamous cell carcinoma (ESCC) and correlate HPV presence with classical risk factors. Methods. Invited patients signed the informed consent form, and interviews were conducted in order to obtain information about sociodemographic and lifestyle behavior. During endoscopy, esophageal biopsies were collected from case and controls. Multiplex polymerase chain reaction genotyping was conducted on endoscopic biopsies to identify HPV types and HPV-16 was further evaluated by specific PCR real time. Results. Among 87 cases, 12 (13.8%) had tumors harboring high risk HPV DNA and among 87 controls, 12 (13.8%) had high risk HPV DNA (OR: 1.025 [CI: 0.405: 2.592]). Variables regarding consumption of alcohol and use of tobacco continued to characterize risk factors even after adjustments by presence or absence of high risk HPV. Conclusion. HPV was demonstrated to be frequently and similarly associated to normal and malignant esophageal tissues, but not as an independent risk factor to esophageal cancer. Impact. To contribute to the Brazilian population data on this subject, which is still contradictory.
Palavras-chave
Human papillomavirus, Esophageal neoplasms, Risk factors, Cancer Epidemiology, Esophageal cancer
Referências
  1. Agarwal S. K., 1998, Indian Journal of Experimental Biology, V36, P559
  2. Antonsson A, 2010, CANCER EPIDEM BIOMAR, V19, P2080, DOI 10.1158/1055-9965.EPI-10-0033
  3. ASHWORTH MT, 1993, J CLIN PATHOL, V46, P573, DOI 10.1136/jcp.46.6.573
  4. AUDIGIER JC, 1975, DIGESTION, V13, P209, DOI 10.1159/000197710
  5. Burd EM, 2003, CLIN MICROBIOL REV, V16, P1, DOI 10.1128/CMR.16.1.1-17.2003
  6. COOPER K, 1995, J PATHOL, V175, P273, DOI 10.1002/path.1711750304
  7. Cousens S., 1995, SELECTION CONTROLS C
  8. Damin APS, 2006, DIS ESOPHAGUS, V19, P64
  9. Far AE, 2007, SCAND J INFECT DIS, V39, P58, DOI 10.1080/00365540600740496
  10. Ferlay J, 2013, GLOBOCAN 2012 V1 0 C
  11. FIDALGO PO, 1995, CANCER, V76, P1522, DOI 10.1002/1097-0142(19951101)76:9<1522::AID-CNCR2820760904>3.0.CO;2-3
  12. Gao GF, 2006, INT J CANCER, V119, P1354, DOI 10.1002/ijc.21980
  13. Gheit T, 2007, J CLIN MICROBIOL, V45, P2537, DOI 10.1128/JCM.00747-07
  14. Gree M., 2012, MOL CLONING LAB MANU
  15. Guo FC, 2012, CANCER EPIDEM BIOMAR, V21, P780, DOI 10.1158/1055-9965.EPI-11-1206
  16. Herbster S, 2012, CANCER LETT, V326, P52, DOI 10.1016/j.canlet.2012.07.018
  17. IARC, 2008, IARC MONOGR EVAL CAR, V96
  18. Kamangar F, 2009, GASTROENTEROL CLIN N, V38, P27, DOI 10.1016/j.gtc.2009.01.004
  19. Kawaguchi H, 2000, CANCER RES, V60, P2753
  20. Khurshid A, 1998, J Pak Med Assoc, V48, P138
  21. Koh JS, 2008, DIS ESOPHAGUS, V21, P114, DOI 10.1111/j.1442-2050.2007.00726.x
  22. Lambot MA, 2000, ACTA GASTRO-ENT BELG, V63, P154
  23. Lenhart D., 1991, DIS ESOPHAGUS, V4, P123
  24. Li T, 2001, CARCINOGENESIS, V22, P929, DOI 10.1093/carcin/22.6.929
  25. Lyronis ID, 2005, INT J BIOL MARKER, V20, P5
  26. Malik SM, 2011, INT J SURG PATHOL, V19, P31, DOI 10.1177/1066896910382005
  27. Matsha T, 2002, J CLIN PATHOL, V55, P587, DOI 10.1136/jcp.55.8.587
  28. Antunes LCM, 2013, WORLD J GASTROENTERO, V19, P6598, DOI 10.3748/wjg.v19.i39.6598
  29. Munoz N, 2006, VACCINE, V24, P1, DOI 10.1016/j.vaccine.2006.05.115
  30. Nunes EM, 2016, VIROLOGY, V495, P33, DOI 10.1016/j.virol.2016.04.031
  31. Pereira M. G., 1995, EPIDEMIOLOGIA TEORIA
  32. RICHART RM, 1991, CURR OPIN OBSTET GYN, V3, P561
  33. Rugge M, 1997, CANCER EPIDEM BIOMAR, V6, P171
  34. Schmitt M, 2006, J CLIN MICROBIOL, V44, P504, DOI 10.1128/JCM.44.2.504-512.2006
  35. SILBER W, 1985, P NUTR SOC, V44, P101, DOI 10.1079/PNS19850016
  36. Syrjanen K, 2013, SCAND J INFECT DIS, V45, P1, DOI 10.3109/00365548.2012.702281
  37. SYRJANEN K, 1982, DIAGN HISTOPATHOL, V5, P291
  38. Syrjanen K, 1996, RECENT ADVANCES IN GASTROENTEROLOGICAL CARCINOGENESIS I, P29
  39. Syrjanen K., 2003, PAPILLOMAVIRUS HUMAI
  40. Syrjanen K., 2000, HPV INFECT OESOPHAGU, P413
  41. SYRJANEN K J, 1987, Archiv fuer Geschwulstforschung, V57, P417
  42. SYRJANEN KJ, 1982, ARCH GESCHWULSTFORSC, V52, P283
  43. Syrjanen KJ, 2002, J CLIN PATHOL, V55, P721, DOI 10.1136/jcp.55.10.721
  44. Syrjanen KJ, 2000, EUROGIN 2000: 4TH INTERNATIONAL MULTIDISCIPLINARY CONGRESS, P169
  45. Takahashi A, 1998, Dis Esophagus, V11, P162
  46. TUYNS AJ, 1983, INT J CANCER, V32, P443, DOI 10.1002/ijc.2910320408
  47. TUYNS AJ, 1979, INT J CANCER, V23, P443, DOI 10.1002/ijc.2910230402
  48. TUYNS AJ, 1970, INT J CANCER, V5, P152, DOI 10.1002/ijc.2910050120
  49. Weston AC, 2003, DIS ESOPHAGUS, V16, P224, DOI 10.1046/j.1442-2050.2003.00333.x
  50. WILLIAMSON AL, 1991, ANTICANCER RES, V11, P263
  51. WYNDER EL, 1961, CANCER, V14, P389, DOI 10.1002/1097-0142(196103/04)14:2<389::AID-CNCR2820140220>3.0.CO;2-E
  52. Zhang QY, 2011, INT J HYG ENVIR HEAL, V214, P156, DOI 10.1016/j.ijheh.2010.11.001